Consensus $550.55M. The company said, “We are increasing our non-GAAP income from operations guidance to be between $106 million and $108 million, compared to non-GAAP loss from operations of $26 million in 2024, reflecting non-GAAP operating margin of 19% at the midpoint.”
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HNGE:
- Hinge Health, Inc.: Strong Market Position and Growth Potential Justify Buy Rating
- Hinge Health target raised, added to ‘Tactical Outperform’ list at Evercore ISI
- Strong Buy Recommendation for Hinge Health, Inc. Amid Market Underestimation and Strategic Growth Potential
- Hinge Health price target raised to $67 from $57 at Morgan Stanley
- Hinge Health: Strong Buy Rating Driven by AI Innovation and Operational Efficiency